Clinical Trial Update: Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized controlled trial of palmitoylethanolamide combined with luteoline for frontotemporal dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Drugs mentioned

• Luteoline (luteolin)
• Palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: I.R.C.C.S. Fondazione Santa Lucia | Conditions: Frontotemporal Dementia | Phase 2 | Status: COMPLETED